Revenue ($USD): $1,667,276,160
Revenue (foreign currencies): 16,869,000,000 SEK kr
R&D spend: $140,150,429.00
Employees: 4,587
Fiscal year end: 04/30/23
CEO: Gustaf Salford
Also this year, Elektaentered into a joint venture with Sinopharmto increase the adoption of radiation therapy in China.–CN